Teammates Deliver Clinical Excellence, Improved Patient Care, Innovation, Robust Partnerships, Community Leadership DENVER, Dec. 26, 2018 /PRNewswire/ — DaVita Inc. (NYSE: DVA), a leading independent medical group and a leading provider of kidney care… Read more
The DaVita Clinical Research (DCR) Biorepository Grant Program (BioReG) was formed support precision-based medicine innovation in nephrology. To see an update of the BioReG Gran Program, please click the… Read more
DaVita physicians and clinical leaders to present on pertinent nephrology topics and research MINNEAPOLIS, Oct. 23, 2018 /PRNewswire/ — DaVita Clinical Research (DCR), a subsidiary of DaVita Inc., (NYSE: DVA), will present 19 research… Read more
DaVita puts its resources toward improving results for some of the sickest patients in American healthcare DENVER, Oct. 3, 2018 /PRNewswire/ — DaVita Inc.(NYSE: DVA), a health care services provider of kidney care, clinical… Read more
Chances are that you or someone you know has faced a cancer diagnosis. It’s also likely that after a diagnosis, the possibility of participating in clinical trials was highlighted. For… Read more
The Nephrology Clinical Trial Best Practices Master Class will take place on September 5, 2018 at the Raleigh Marriott Crabtree Valley Hotel in Raleigh, NC. Join DaVita Clinical Research and… Read more
Erika Maxwell, a Phase 3 clinical trial participant, shares her experience of participating in a clinical trial with DaVita Clinical Research. #iSupportResearch Read more
Patient enrollment for clinical trials can be a challenging task especially if the patients are dealing with a chronic illness. Dialysis patients in particular are a population that need a… Read more
Research can create better futures for people on dialysis, those who care for them in clinics and those who care for them at home. However, many aspects of dialysis research… Read more
MINNEAPOLIS (April 9, 2018) – DaVita Clinical Research (DCR), a specialty contract research organization and subsidiary of DaVita Inc. (NYSE: DVA) with services spanning the full spectrum of drug and… Read more